a clinical device designed for to detect various types of cancer is being tested in the UK. The initiative promoted by the Cancer research in the UK be tested for two years in order to demonstrate whether the encouragement of a person may indicate the presence of cancer.
The call biopsy of the breath tries to find out if the molecules expelled in the air can be useful for detection of this disease. According to recent research, it is believed that cancer It can create a different pattern of volatile organic compounds (VOCs), which you have found in the molecules produced in the body's normal metabolic processes, CNN Chile reported.
"Our goal is to find out if we can detect these subtle differences," said co-founder and CEO of Owlstone Medical, which developed the device, to CNN. Billy Boyle.
For this, the Cancer Research Center from UK, which runs the project, is recruiting up to 1,500 participants, including healthy people to act as a control group.
In the first place, the participation of patients with stomach cancer and esophagus, then expand the tests for those who have cancer of the prostate, kidney, liver, pancreas and bladder.
Participants will be invited to breathe in the device for 10 minutes in order to obtain a sample that will be analyzed by the laboratory. Owlstone Medical in Cambridge. This will enable you to identify whether cancer They are similar or different in addition to how much time is needed to detect them.
If during the study some participants develop cancer, your samples will be compared to those that do not develop the disease.
"We urgently need to develop new tools, such as this breathing test, that could help detect and diagnose cancer before, giving patients the best chance of surviving the disease, "said the professor. Rebecca Fitzgeraldprincipal investigator of the study Cancer research in the UK Cambridge Center.
Along the same lines, co-founder and CEO of Owlstone Medical, Billy Boyle, it's him Cancer Research they agree that breathing biopsies They are a success that are used in doctors' practices to determine if patients need to be referred to other diagnostic tests. "Through this clinical trial, we hope to find the tests needed to detect cancers rather, it is the next crucial step in the development of this technology, "he said. Fitzgerald in a statement.